The use of weight-loss drugs such as Wegovy and Ozempic has climbed among children in the United States, according to a study released Wednesday.
The study examined data from 2020 to 2023 from the IQVIA prescription database and found that about 31,000 children aged 12 to 17 used weight-loss drugs in 2023 alone. About 162,000 adults aged 18 to 25 also used the drugs in 2023.
“What it’s suggesting is that it’s one of the tools in the toolbox and there are more providers prescribing this medication for the population,” Joyce Lee, a University of Michigan pediatrician and diabetes expert, told the outlet. The number of children using weight-loss drugs climbed dramatically between 2020 and 2023, according to the report, going from 8,700 a month to more than 60,000, almost a seven-fold increase.
In 2023, more than 6,000 children received the weight-loss drug Wegovy, and more than 7,600 received Ozempic, a sought-after drug in the wake ofturning to it. A lineup of celebrities who have either disclosed their use of the drug or hailed its weight-dropping properties includes Khloe Kardashian, Oprah Winfrey, Amy Schumer, and Elon Musk.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk To Slash Prices On Buzzy Drugs Ozempic and WegovyScience and Technology News and Videos
Read more »
Novo Nordisk announces $6B investment in Ozempic, Wegovy amid shortagesNovo Nordisk's Negelle Morris spoke exclusively with ABC News.
Read more »
Sanders Launches Probe of 'Outrageously Overpriced' Ozempic and WegovyBrett Wilkins is a staff writer for Common Dreams.
Read more »
US Senate committee investigates pricing of Novo's Ozempic and WegovyUS Senate committee investigates pricing of Novo's Ozempic and Wegovy
Read more »
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.Before insurance, Novo Nordisk charges about $1,000 per month for Ozempic in the United States. In Germany, the company charges $59 a month for the same drug.
Read more »
US Senate committee investigates pricing of Novo's Ozempic and WegovyA U.S. Senate committee said on Wednesday it had launched an investigation into the prices of Novo Nordisk's diabetes and weight loss drugs Ozempic and Wegovy in the United States.
Read more »